Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Plasma for Fractionation Market by Type (Recovered Plasma, Source Plasma), By Application (Coagulation Factor, Immune Globulin, Albumin, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Plasma for Fractionation Market by Type (Recovered Plasma, Source Plasma), By Application (Coagulation Factor, Immune Globulin, Albumin, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 262908 4200 Pharma & Healthcare 377 222 Pages 4.7 (45)
                                          

Market Overview:


The global plasma for fractionation market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for coagulation factor, immune globulin, albumin and other therapeutic proteins. In addition, rising prevalence of chronic diseases and increasing number of blood transfusions are also contributing to the growth of this market. On the basis of type, recovered plasma accounted for the largest share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high purity and low cost as compared to source plasma.


Global Plasma for Fractionation Industry Outlook


Product Definition:


Plasma is the liquid component of blood, in which the red blood cells are suspended. Plasma makes up about 55% of the total volume of blood. It is a straw-colored fluid that contains nutrients, proteins, electrolytes, and hormones. Plasma also contains clotting factors and other proteins that help to fight infection.


Recovered Plasma:


Recovered plasma is a by-product obtained during the fractionation process of blood plasma. It consists of protein, nucleic acids, and some minerals. The amount of recovered plasma varies with the volume of blood collected and processing conditions (temperature & pressure).


Source Plasma:


Plasma is a blood-based liquid that can separate any two substances based on their properties. It's used in fractionation for the separation of different components in a mixture. Source plasma is taken from whole blood and it contains all the clotting factors, which enables its use as a reliable source for fractionation.


Source Plasma helps to improve yield & purity.


Application Insights:


The coagulation factor segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to an increase in demand for recombinant activated protein C (rAPC) as a blood thinner, which is derived from plasma. rAPC has been approved by U.S. FDA and European Commission (CE Marking) for use in treating hemophilia A and B patients, respectively, leading to increased product consumption across the globe since 2016.


Plasma-based products are also used for manufacturing various pharmaceuticals including immune globulin (IG), albumin, insulinotropic peptides such as human insulin or neutralizing antibodies against tumor-associated antigens such as epidermal growth factor receptor (EGFR).


Regional Analysis:


North America dominated the market in 2017 owing to the presence of a large number of players and well-established healthcare infrastructure. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities for plasma fractionation and rising adoption of advanced technologies. In addition, growing demand for plasma products from various end-use sectors such as medical & surgical, military & defense, blood donation is also expected to drive growth in this region.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing with rapid economic development coupled with improving healthcare infrastructure in countries such as India and China. Furthermore, rising awareness regarding blood donations among people especially youth will boost regional market growth during the projected time frame. Favorable government initiatives aimed at promoting exports from developing economies are further anticipated fuel regional market expansion over next eight years (2030).


Growth Factors:


  • Increasing demand for plasma fractionation products due to increasing incidence of chronic diseases such as cancer, autoimmune disorders, and genetic disorders.
  • Technological advancements in the field of plasma fractionation that has led to the development of novel and improved products.
  • Growing number of private-sector players in the market that is resulting in increased competition and innovation.
  • Rising awareness about the benefits of using plasma fractionation products among healthcare professionals and consumers alike.

Scope Of The Report

Report Attributes

Report Details

Report Title

Plasma for Fractionation Market Research Report

By Type

Recovered Plasma, Source Plasma

By Application

Coagulation Factor, Immune Globulin, Albumin, Others

By Companies

Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

222

Number of Tables & Figures

156

Customization Available

Yes, the report can be customized as per your need.


Global Plasma for Fractionation Market Report Segments:

The global Plasma for Fractionation market is segmented on the basis of:

Types

Recovered Plasma, Source Plasma

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Coagulation Factor, Immune Globulin, Albumin, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Takeda
  2. CSL
  3. Grifols
  4. Octapharma
  5. Kedrion
  6. LFB Group
  7. Biotest
  8. BPL
  9. RAAS
  10. CBPO
  11. Hualan Bio

Global Plasma for Fractionation Market Overview


Highlights of The Plasma for Fractionation Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Recovered Plasma
    2. Source Plasma
  1. By Application:

    1. Coagulation Factor
    2. Immune Globulin
    3. Albumin
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Plasma for Fractionation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Plasma for Fractionation Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Plasma is a gas that is made up of atoms and molecules. It can be used to fractionate substances by breaking them down into their component parts. This process allows scientists to identify and study the individual chemicals in a sample more easily.

Some of the major players in the plasma for fractionation market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio.

The plasma for fractionation market is expected to grow at a compound annual growth rate of 6.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plasma for Fractionation Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Plasma for Fractionation Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Plasma for Fractionation Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Plasma for Fractionation Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Plasma for Fractionation Market Size & Forecast, 2018-2028       4.5.1 Plasma for Fractionation Market Size and Y-o-Y Growth       4.5.2 Plasma for Fractionation Market Absolute $ Opportunity

Chapter 5 Global Plasma for Fractionation Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Plasma for Fractionation Market Size Forecast by Type
      5.2.1 Recovered Plasma
      5.2.2 Source Plasma
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Plasma for Fractionation Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Plasma for Fractionation Market Size Forecast by Applications
      6.2.1 Coagulation Factor
      6.2.2 Immune Globulin
      6.2.3 Albumin
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Plasma for Fractionation Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Plasma for Fractionation Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Plasma for Fractionation Analysis and Forecast
   9.1 Introduction
   9.2 North America Plasma for Fractionation Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Plasma for Fractionation Market Size Forecast by Type
      9.6.1 Recovered Plasma
      9.6.2 Source Plasma
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Plasma for Fractionation Market Size Forecast by Applications
      9.10.1 Coagulation Factor
      9.10.2 Immune Globulin
      9.10.3 Albumin
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Plasma for Fractionation Analysis and Forecast
   10.1 Introduction
   10.2 Europe Plasma for Fractionation Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Plasma for Fractionation Market Size Forecast by Type
      10.6.1 Recovered Plasma
      10.6.2 Source Plasma
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Plasma for Fractionation Market Size Forecast by Applications
      10.10.1 Coagulation Factor
      10.10.2 Immune Globulin
      10.10.3 Albumin
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Plasma for Fractionation Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Plasma for Fractionation Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Plasma for Fractionation Market Size Forecast by Type
      11.6.1 Recovered Plasma
      11.6.2 Source Plasma
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Plasma for Fractionation Market Size Forecast by Applications
      11.10.1 Coagulation Factor
      11.10.2 Immune Globulin
      11.10.3 Albumin
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Plasma for Fractionation Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Plasma for Fractionation Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Plasma for Fractionation Market Size Forecast by Type
      12.6.1 Recovered Plasma
      12.6.2 Source Plasma
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Plasma for Fractionation Market Size Forecast by Applications
      12.10.1 Coagulation Factor
      12.10.2 Immune Globulin
      12.10.3 Albumin
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Plasma for Fractionation Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Plasma for Fractionation Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Plasma for Fractionation Market Size Forecast by Type
      13.6.1 Recovered Plasma
      13.6.2 Source Plasma
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Plasma for Fractionation Market Size Forecast by Applications
      13.10.1 Coagulation Factor
      13.10.2 Immune Globulin
      13.10.3 Albumin
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Plasma for Fractionation Market: Competitive Dashboard
   14.2 Global Plasma for Fractionation Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Takeda
      14.3.2 CSL
      14.3.3 Grifols
      14.3.4 Octapharma
      14.3.5 Kedrion
      14.3.6 LFB Group
      14.3.7 Biotest
      14.3.8 BPL
      14.3.9 RAAS
      14.3.10 CBPO
      14.3.11 Hualan Bio

Our Trusted Clients

Contact Us